期刊文献+

885例前列腺特异性抗原检测分析

下载PDF
导出
摘要 目的通过总结885例前列腺特异性抗原(PSA)检测结果 ,探讨其对前列腺疾病诊断的灵敏度和特异性,了解其临床应用价值。方法采用化学发光法测定血清PSA。结果通过测定885例患者血清PSA,发现前列腺癌4例(0.45%),前列腺增生23例(2.60%),前列腺炎28例(3.16%)。结论 PSA在诊断前列腺疾病中有较高的价值,且该方法简便、易行、准确性高,适合在基层医院推广。
作者 苑瑞琴
出处 《检验医学与临床》 CAS 2010年第9期842-843,共2页 Laboratory Medicine and Clinic
  • 相关文献

参考文献7

  • 1Bunting PS.Screening for prostate cancer with prostate-specific antigen:beware the biases[J].Clin Chim Acta,2002,315(1/2):71-97.
  • 2Djavan B,Zlotta A,Kratzik C,et al.PSA,PSA density,PSA-density of transition zone,free/total PSA ratio,and PSA velocity forearly detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL[J].Urology,1999,54(3):517-522.
  • 3曹希亮,高江平,韩刚,唐杰,洪宝发.以前列腺特异抗原水平分组筛查与前列腺穿刺阳性率的关系[J].中华外科杂志,2006,44(6):372-375. 被引量:21
  • 4Catalona WJ,Richie LP,Ahmann FR,et al.Comparison ofgen in the early defection of prostate cancer:results of amulticenter clinical trial of 66 330 men[J].J Urol,1994,151:1283-1286.
  • 5Stamey TA,Caldwell M,McNeal JE,et al.The prostate specific antigen era in the United States is over for prostate cancer:What happened in the last 20 years[J].J Urol,2004,172:1297-1301.
  • 6Vergho DC,Heine K,Wolff JM.The role of PSA in diagnosis of prostate cancer and its recurrence[J].Pathologe,2005,26(6):473-478.
  • 7李元杰,张国平.泌尿系肿瘤患者血清PSA的IRMA检测分析[J].医学理论与实践,2002,15(12):1395-1396. 被引量:6

二级参考文献17

  • 1赵耀瑞,徐勇,张殿举,畅继武,张淑敏,史启铎,孙光,韩瑞发,姚庆祥,马腾骧.血清PSA、PSAD和PSAT在前列腺穿刺活检中的意义[J].中华泌尿外科杂志,2005,26(9):622-625. 被引量:35
  • 2Roobol MJ,Kranse R,de Koning HJ,et al.Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer:results of second screening round of ERSPC (ROTTERDAM).Urology,2004,63:309-313.
  • 3Thompson IM,Pauler DK,Goodman PJ,et al.Prevalence of prostate cancer among men with a prostate-specific antigen level < or=4.0 ng per milliliter.N Engl J Med,2004,350:2239-2246.
  • 4Kobayashi T,Nishizawa K,Ogura K,et al.Detection of prostate cancer in men with prostate-specific antigen levels of 2.0 to 4.0 ng/mL equivalent to that in men with 4.1 to 10.0 ng/mL in a Japanese population.Urology,2004,63:727-731.
  • 5Brawe MK.The diagnosis of prostatic carcinoma.Cancer,1993,71(3 Suppl):899-905.
  • 6Kuwahara M,Tochigi T,Kawamura S,et al.Mass screening for prostate cancer:a comparative study in Natori,Japan and Changchun,China.Urology,2003,61:137-141.
  • 7Yu HJ,Chie WC,Hsieh CH,et al.Clinical efficacy of prostate-specific antigen testing in patients with prostatic disease.J Formos Med Assoc,1996,95:782-788.
  • 8Khan MA,Carter HB,Epstein JI,et al.Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer? J Urol,2003,170(6 Pt 1):2274-2278.
  • 9Punglia RS,D′Amico AV,Catalona WJ,et al.Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.N Engl J Med,2003,349:335-342.
  • 10Schroder FH,van der Maas P,Beemsterboer P,et al.Evaluation of the digital rectal examination as a screening test for prostate cancer.Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.J Natl Cancer Inst,1998,90:1817-1823.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部